Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz Germany after medical education at the University of Mainz and the University of California in San Francisco. He trained as both an imager and interventional cardiologist. He is the head of the CV imaging department since 2004.
He was speaker of the national WG on cardiovascular ultrasound in 2016-2018 and nucleus member in valvular heart disease. His department includes CV imaging and interventions as well as grown-up congenital heart disease.
The Heart Valve Center in Mainz is one of the leading centers for percutaneous valve therapy in Germany and one of the leading worldwide centers in Mitral and Tricuspid valve interventions.
His department participated in a number of early in man implantations (MitraClip NT(r)/XTr, Cardioband MR and TR, PASCAL) and is Corelab for RESHAPE-II, Matterhorn, TRIC and other international trials.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease